1,2-dipalmitoylphosphatidylcholine has been researched along with imatinib mesylate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Béni, S; Budai, M; Gróf, P; Noszál, B | 1 |
| Chiorcea-Paquim, AM; Diculescu, VC; Oliveira-Brett, AM; Tugulea, L; Vivan, M | 1 |
| Jose, A; Karnam, S; Ninave, KM; Venuganti, VVK | 1 |
3 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and imatinib mesylate
| Article | Year |
|---|---|
Molecular interactions in imatinib-DPPC liposomes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents; Benzamides; Calorimetry, Differential Scanning; Drug Compounding; Drug Interactions; Electron Spin Resonance Spectroscopy; Hydrogen-Ion Concentration; Imatinib Mesylate; Liposomes; Membrane Fluidity; Microscopy, Electron, Transmission; Piperazines; Pyrimidines; Surface Properties; Temperature | 2006 |
Interaction of imatinib with liposomes: voltammetric and AFM characterization.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Benzamides; Electrochemistry; Graphite; Hydrogen Bonding; Imatinib Mesylate; Lipid Bilayers; Liposomes; Microscopy, Atomic Force; Phosphatidylcholines; Piperazines; Pyrimidines | 2009 |
Temperature-sensitive liposomes for co-delivery of tamoxifen and imatinib for synergistic breast cancer treatment.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Compounding; Drug Liberation; Female; Humans; Imatinib Mesylate; Liposomes; Lysophosphatidylcholines; Nanoparticles; Tamoxifen; Temperature | 2019 |